Amy W. Schulman, Director: Alnylam Pharmaceuticals ALNY Sell · Filed 24/05/31

Trade details

Type: Insider sale
Amount: $1,500,033.41
Shares · price: 10,121 sh · $148.21 a share
Held after: 20,015 sh
Stock: Alnylam Pharmaceuticals ALNY
Person: Amy W. SchulmanDirector
Trade date: 24/05/29
Filed: 24/05/31
Days to filing: 2 days

Sold 33.6% of holdings

Share of holding sold: 33.6%

Alnylam Pharmaceuticals trades, last 26 weeks

What else happened in Alnylam Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 24/04/29~24/06/28

Amy W. Schulman's recent trades

Amy W. SchulmanDirector
SellElevance Health
Sell
Elevance Health
ELV
$7,475
26 sh
$7,475
Filed 03/23
Traded 03/12
Amy W. SchulmanDirector
BuyFractyl Health
Buy
Fractyl Health
GUTS
$10K
8,550 sh
$10K
Filed 25/03/17
Traded 25/03/13
Amy W. Schulman10% Owner
BuyCamp4 Therapeutics
Buy
Camp4 Therapeutics
CAMP
$10M
909,090 sh
$10M
Filed 24/10/15
Traded 24/10/15
Amy W. SchulmanDirector
Sell10b5-1 planAlnylam Pharmaceuticals
Sell10b5-1 plan
Alnylam Pharmaceuticals
ALNY
$2M
8,500 sh
$2M
Filed 24/06/27
Traded 24/06/25
Amy W. SchulmanDirector
Sell10b5-1 planAlnylam Pharmaceuticals
Sell10b5-1 plan
Alnylam Pharmaceuticals
ALNY
$1.7M
11,516 sh
$1.7M
Filed 24/05/31
Traded 24/05/29

Amy W. Schulman, Director — sold $1.5M of Alnylam Pharmaceuticals ALNY · 33.6% of holdings · 10b5-1 plan | Whalegun